التفاصيل البيبلوغرافية
| العنوان: |
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study |
| المؤلفون: |
Shi, Yuankai, Wu, Shiman, Wang, Ke, Cang, Shundong, Yao, Wenxiu, Fan, Yun, Wu, Lin, Huang, Meijuan, Li, Xingya, Pan, Yueyin, Yang, Zhixiong, Zhu, Bo, Chen, Gongyan, Shi, Jianhua, Sun, Meili, Fang, Jian, Wang, Lijun, Chen, Zhaohong, Liu, Chunling, Li, Jingzhang, Liu, Jiwei, Sun, Shenghua, Zhao, Yanqiu, Guo, Yanzhen, Meng, Zili, Liu, Zhefeng, Han, Zhigang, Lu, Hong, Ma, Rui, Hu, Sheng, Zhao, Guofang, Liu, Zheng, Xie, Congying, Zhong, Diansheng, Zhao, Hui, Yu, Huiqing, Zhang, Longzhen, Bi, Minghong, Yi, Shanyong, Guo, Shuliang, Yi, Tienan, Li, Wen, Lin, Yingcheng, Shu, Yongqian, Chen, Zhendong, Guo, Zhongliang, Greco, Michael, Wang, Tingting, Shen, Haijiao |
| المصدر: |
In Journal of Thoracic Oncology November 2022 17(11):1306-1317 |
| قاعدة البيانات: |
ScienceDirect |
